2.9M
XNAS Volume
High volume+loss today
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Anthony Koblish | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 21 Feb 2025 | 5,772 | 590,494 (5%) | 0% | 2.7 | 15,296 | Common Stock |
| Anthony Koblish | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 11,631 | 596,266 (5%) | 0% | 2.7 | 31,636 | Common Stock |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 149,000 | 607,897 (5%) | 1% | 0 | Common Stock | |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 219,000 | 219,000 | - | - | Stock Option (Right to Buy) | |
| Roberto Cuca | COO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 5,234 | 208,233 (1%) | 0% | 2.7 | 14,236 | Common Stock |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 83,800 | 83,800 | - | - | Stock Option (Right to Buy) | |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 57,000 | 213,467 (1%) | 0% | 0 | Common Stock | |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 1,590 | 37,889 (0%) | 0% | 2.7 | 4,325 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 21 Feb 2025 | 539 | 36,927 (0%) | 0% | 2.6 | 1,428 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 423 | 37,466 (0%) | 0% | 2.7 | 1,151 | Common Stock |
| Paul Talmo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 38,100 | 129,182 (1%) | 0% | 0 | Common Stock | |
| Paul Talmo | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 21 Feb 2025 | 1,049 | 124,072 (1%) | 0% | 2.7 | 2,780 | Common Stock |
| Paul Talmo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 56,100 | 56,100 | - | - | Stock Option (Right to Buy) | |
| Paul Talmo | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 4,061 | 125,121 (1%) | 0% | 2.7 | 11,046 | Common Stock |
| Gregory A. Firestone | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 1,352 | 107,163 (0%) | 0% | 2.7 | 3,677 | Common Stock |
| Gregory A. Firestone | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 51,600 | 108,879 (0%) | 0% | 0 | Common Stock | |
| Gregory A. Firestone | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 364 | 108,515 (0%) | 0% | 2.7 | 990 | Common Stock |
| Gregory A. Firestone | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 21 Feb 2025 | 240 | 106,923 (0%) | 0% | 2.7 | 636 | Common Stock |
| Gregory A. Firestone | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 75,900 | 75,900 | - | - | Stock Option (Right to Buy) | |
| Megan Smeykal | Chief Accounting Officer, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 9,400 | 39,479 (0%) | 0% | 0 | Common Stock | |
| Anthony Koblish | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 24 Oct 2024 | 88,888 | 458,897 (4%) | 0% | 2.3 | 199,998 | Common Stock |
| Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 24 Oct 2024 | 64,444 | 155,388 (1%) | 0% | 2.3 | 144,999 | Common Stock |
| Paul Talmo | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 24 Oct 2024 | 22,222 | 91,082 (0%) | 0% | 2.3 | 50,000 | Common Stock |
| Gregory A. Firestone | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 24 Oct 2024 | 6,666 | 57,279 (0%) | 0% | 2.3 | 14,999 | Common Stock |
| Gregory A. Firestone | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.25 per share. | 03 Aug 2024 | 1,093 | 50,613 (0%) | 0% | 4.2 | 4,645 | Common Stock |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,250 | 10,520 (0%) | 0% | 0 | Common Stock | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,250 | 15,380 (0%) | 0% | 0 | Common Stock | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,250 | 10,520 (0%) | 0% | 0 | Common Stock | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,250 | 10,520 (0%) | 0% | 0 | Common Stock | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,300 | 9,300 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Blizard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,375 | 6,375 (0%) | 0% | 0 | Common Stock | |
| Anthony Koblish | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 31 Mar 2024 | 385 | 370,009 (3%) | 0% | 5.7 | 2,183 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 31 Mar 2024 | 163 | 48,129 (0%) | 0% | 5.7 | 924 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 31 Mar 2024 | 96 | 29,000 (0%) | 0% | 5.7 | 544 | Common Stock |
| Paul Talmo | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 31 Mar 2024 | 190 | 68,860 (0%) | 0% | 5.7 | 1,077 | Common Stock |
| Gregory A. Firestone | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 31 Mar 2024 | 119 | 50,627 (0%) | 0% | 5.7 | 675 | Common Stock |
| Paul Talmo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 16,700 | 72,676 (0%) | 0% | 0 | Common Stock | |
| A. Firestone Gregory | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 240 | 50,986 (0%) | 0% | 7.1 | 1,697 | Common Stock |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 113,200 | 113,200 | - | - | Stock Option (Right to Buy) | |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 940 | 48,292 (0%) | 0% | 7.1 | 6,646 | Common Stock |
| Smeykal Megan | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 423 | 29,635 (0%) | 0% | 7.1 | 2,991 | Common Stock |
| Talmo Paul | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 2,577 | 70,099 (0%) | 0% | 7.1 | 18,219 | Common Stock |
| Gregory Firestone A. | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cuca Roberto | COO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 2,785 | 89,865 (0%) | 0% | 7.1 | 19,690 | Common Stock |
| Talmo Paul | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 1,049 | 69,050 (0%) | 0% | 7.1 | 7,416 | Common Stock |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 29,200 | 92,650 (0%) | 0% | 0 | Common Stock | |
| Koblish Anthony | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 5,014 | 376,120 (3%) | 0% | 7.1 | 35,449 | Common Stock |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 77,500 | 381,134 (3%) | 0% | 0 | Common Stock | |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 539 | 29,096 (0%) | 0% | 7.1 | 3,811 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 19,300 | 19,300 | - | - | Stock Option (Right to Buy) | |
| Cuca Roberto | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 42,700 | 42,700 | - | - | Stock Option (Right to Buy) | |
| A. Gregory Firestone | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 240 | 50,746 (0%) | 0% | 7.1 | 1,697 | Common Stock |
| Talmo Paul | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 24,400 | 24,400 | - | - | Stock Option (Right to Buy) | |
| Murphy Peter C. | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 2,315 | 49,232 (0%) | 0% | 7.1 | 16,367 | Common Stock |
| Gregory Firestone A. | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 15,000 | 51,226 (0%) | 0% | 0 | Common Stock | |
| Koblish Anthony | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 5,726 | 370,394 (3%) | 0% | 7.1 | 40,483 | Common Stock |
| C. Murphy Peter | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 13,200 | 51,547 (0%) | 0% | 0 | Common Stock | |
| Smeykal Megan | Chief Accounting Officer, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 9,400 | 30,058 (0%) | 0% | 0 | Common Stock | |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 21 Feb 2024 | 795 | 20,658 (0%) | 0% | 7 | 5,565 | Common Stock |
| A. Firestone Gregory | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 21 Feb 2024 | 364 | 36,226 (0%) | 0% | 7 | 2,548 | Common Stock |
| Firestone A. Gregory | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 5.65 per share. | 05 Dec 2023 | 2,600 | 35,511 (0%) | 0% | 5.6 | 14,688 | Common Stock |
| Gregory A. Firestone | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 17,950 | 32,911 (0%) | 0% | 0 | Common Stock | |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,135 | 6,270 (0%) | 0% | 0 | Common Stock | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,135 | 11,130 (0%) | 0% | 0 | Common Stock | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,135 | 6,270 (0%) | 0% | 0 | Common Stock | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,135 | 6,270 (0%) | 0% | 0 | Common Stock | |
| John E. Nosenzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,135 | 6,270 (0%) | 0% | 0 | Common Stock | |
| John E. Nosenzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Anthony Koblish | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Mar 2023 | 385 | 292,634 (2%) | 0% | 10.6 | 4,096 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Mar 2023 | 163 | 37,987 (0%) | 0% | 10.6 | 1,734 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Mar 2023 | 96 | 20,431 (0%) | 0% | 10.6 | 1,021 | Common Stock |
| Paul Talmo | Chief Strategic Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Mar 2023 | 187 | 55,976 (0%) | 0% | 10.6 | 1,990 | Common Stock |
| Vincent J. Burgess | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,860 | 0 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Burgess | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.44 per share. | 29 Mar 2023 | 4,860 | 7,995 (0%) | 0% | 4.4 | 21,578 | Common Stock |
| Anthony Koblish | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 61,200 | 299,053 (2%) | 0% | 0 | Common Stock | |
| Anthony Koblish | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 96,100 | 96,100 | - | - | Stock Option (Right to Buy) | |
| Anthony Koblish | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share. | 23 Feb 2023 | 6,034 | 293,019 (2%) | 0% | 11.0 | 66,555 | Common Stock |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 17,700 | 52,592 (0%) | 0% | 0 | Common Stock | |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,700 | 27,700 | - | - | Stock Option (Right to Buy) | |
| Roberto Cuca | COO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 23 Feb 2023 | 1,300 | 51,292 (0%) | 0% | 10.5 | 13,650 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share. | 23 Feb 2023 | 940 | 38,150 (0%) | 0% | 11.0 | 10,368 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 16,800 | 39,996 (0%) | 0% | 0 | Common Stock | |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 23 Feb 2023 | 906 | 39,090 (0%) | 0% | 10.5 | 9,513 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 23 Feb 2023 | 423 | 21,066 (0%) | 0% | 10.5 | 4,442 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share. | 23 Feb 2023 | 539 | 20,527 (0%) | 0% | 11.0 | 5,945 | Common Stock |
| Paul Talmo | Chief Strategic Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 23 Feb 2023 | 1,067 | 57,195 (0%) | 0% | 10.5 | 11,204 | Common Stock |
| Paul Talmo | Chief Strategic Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share. | 23 Feb 2023 | 1,032 | 56,163 (0%) | 0% | 11.0 | 11,383 | Common Stock |
| Paul Talmo | Chief Strategic Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Paul Talmo | Chief Strategic Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 16,800 | 58,262 (0%) | 0% | 0 | Common Stock | |
| Megan Smeykal | Chief Accounting Officer, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 9,400 | 21,489 (0%) | 0% | 0 | Common Stock | |
| Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 07 Jun 2022 | 15,000 | 34,892 (0%) | 0% | 5.5 | 82,500 | Common Stock |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,135 | 3,135 (0%) | 0% | 0 | Common Stock | |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,135 | 3,135 (0%) | 0% | 0 | Common Stock | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,135 | 3,135 (0%) | 0% | 0 | Common Stock | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,135 | 3,135 (0%) | 0% | 0 | Common Stock | |
| John E. Nosenzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,135 | 3,135 (0%) | 0% | 0 | Common Stock | |
| John E. Nosenzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| Anthony Koblish | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.63 per share. | 31 Mar 2022 | 384 | 237,853 (2%) | 0% | 11.6 | 4,466 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.63 per share. | 31 Mar 2022 | 163 | 23,196 (0%) | 0% | 11.6 | 1,896 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.63 per share. | 31 Mar 2022 | 93 | 12,089 (0%) | 0% | 11.6 | 1,082 | Common Stock |
| Paul Talmo | Chief Strategic Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.63 per share. | 31 Mar 2022 | 185 | 41,462 (0%) | 0% | 11.6 | 2,152 | Common Stock |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 79,500 | 79,500 | - | - | Stock Option (Right to Buy) | |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 46,500 | 240,924 (2%) | 0% | 0 | Common Stock | |
| Anthony Koblish | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 24 Feb 2022 | 2,687 | 238,237 (2%) | 0% | 12.0 | 32,190 | Common Stock |
| Ellis Skott Greenhalgh | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 24 Feb 2022 | 973 | 27,826 (0%) | 0% | 12.0 | 11,657 | Common Stock |
| Peter C. Murphy | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 24 Feb 2022 | 939 | 23,359 (0%) | 0% | 12.0 | 11,249 | Common Stock |
| Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 24 Feb 2022 | 535 | 12,182 (0%) | 0% | 12.0 | 6,409 | Common Stock |
| Paul Talmo | Chief Strategic Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 24 Feb 2022 | 1,023 | 41,647 (0%) | 0% | 12.0 | 12,256 | Common Stock |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 15,500 | 19,892 (0%) | 0% | 0 | Common Stock | |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 26,600 | 26,600 | - | - | Stock Option (Right to Buy) | |
| Ellis Skott Greenhalgh | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 6,675 | 6,675 | - | - | Stock Option (Right to Buy) | |
| Ellis Skott Greenhalgh | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 3,900 | 28,799 (0%) | 0% | 0 | Common Stock | |
| Paul Talmo | Chief Strategic Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 12,200 | 42,670 (0%) | 0% | 0 | Common Stock | |
| Paul Talmo | Chief Strategic Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.67 per share. | 02 Dec 2021 | 1,351 | 4,392 (0%) | 0% | 12.7 | 17,117 | Common Stock |
| Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.64 per share. | 29 Nov 2021 | 1,780 | 3,041 (0%) | 0% | 12.6 | 22,499 | Common Stock |
| Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.43 per share. | 29 Nov 2021 | 838 | 1,261 (0%) | 0% | 12.4 | 10,416 | Common Stock |
| Roberto Cuca | COO and CFO | Purchase of securities on an exchange or from another person at price $ 12.60 per share. | 29 Nov 2021 | 423 | 423 (0%) | 0% | 12.6 | 5,330 | Common Stock |
| Roberto Cuca | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Lisa N. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,825 | 10,825 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,825 | 10,825 | - | - | Stock Option (Right to Buy) | |
| Kurt Azarbarzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,825 | 10,825 | - | - | Stock Option (Right to Buy) | |
| Federica O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,825 | 10,825 | - | - | Stock Option (Right to Buy) | |
| John E. Nosenzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 5,439 | 194,424 (1%) | 0% | 0 | Common Stock | |
| Nora E. Brennan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 2,928 | 17,696 (0%) | 0% | 0 | Common Stock | |
| Ellis Skott Greenhalgh | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 2,789 | 24,899 (0%) | 0% | 0 | Common Stock | |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 2,298 | 13,498 (0%) | 0% | 0 | Common Stock | |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 34,900 | 188,985 (1%) | 0% | 0 | Common Stock | |
| Anthony Koblish | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 63,600 | 63,600 | - | - | Common Stock (right to buy) | |
| Maarten Persenaire | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 12,000 | 90,887 (0%) | 0% | 0 | Common Stock | |
| Maarten Persenaire | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 21,800 | 21,800 | - | - | Stock Option (right to buy) | |
| Nora E. Brennan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 20,100 | 20,100 | - | - | Stock Option (right to buy) | |
| Nora E. Brennan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 11,100 | 14,768 (0%) | 0% | 0 | Common Stock | |
| Ellis Skott Greenhalgh | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Ellis Skott Greenhalgh | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 11,600 | 22,110 (0%) | 0% | 0 | Common Stock | |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 20,400 | 20,400 | - | - | Stock Option (right to buy) | |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 11,200 | 11,200 (0%) | 0% | 0 | Common Stock | |
| Lisa N. Colleran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 8,806 | 8,806 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Burgess | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 8,806 | 8,806 | - | - | Stock Option (Right to Buy) | |
| Adele C. Oliva | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 8,806 | 8,806 | - | - | Stock Option (Right to Buy) | |
| Kurt Azarbarzin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 8,806 | 8,806 | - | - | Stock Option (Right to Buy) | |
| Federica O'Brien | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 8,806 | 8,806 | - | - | Stock Option (Right to Buy) | |
| Lisa N. Colleran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2020 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Peter C. Murphy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Anthony Koblish | Director, Chief Executive Officer | 13 Nov 2019 | 7,277 | 139,860 (1%) | 0% | 0 | Common Stock | ||
| Anthony Koblish | Director, Chief Executive Officer | 13 Nov 2019 | 10,775 | 10,775 | - | - | Warrant (right to buy) | ||
| Anthony Koblish | Director, Chief Executive Officer | 13 Nov 2019 | 10,775 | 0 | - | - | Warrant (right to buy) | ||
| Anthony Koblish | Director, Chief Executive Officer | 13 Nov 2019 | 351,271 | 0 | - | - | Series B Preferred Stock | ||
| Anthony Koblish | Director, Chief Executive Officer | 13 Nov 2019 | 179,685 | 0 | - | - | Series A Preferred Stock | ||
| Anthony Koblish | Director, Chief Executive Officer | 13 Nov 2019 | 14,225 | 154,085 (1%) | 0% | 0 | Common Stock | ||
| Maarten Persenaire | Chief Medical Officer | 13 Nov 2019 | 7,999 | 66,127 (0%) | 0% | 0 | Common Stock | ||
| Maarten Persenaire | Chief Medical Officer | 13 Nov 2019 | 12,931 | 12,931 | - | - | Warrant (right to buy) | ||
| Maarten Persenaire | Chief Medical Officer | 13 Nov 2019 | 12,931 | 0 | - | - | Warrant (right to buy) | ||
| Maarten Persenaire | Chief Medical Officer | 13 Nov 2019 | 315,086 | 0 | - | - | Series B Preferred Stock | ||
| Maarten Persenaire | Chief Medical Officer | 13 Nov 2019 | 197,511 | 0 | - | - | Series A Preferred Stock | ||
| Maarten Persenaire | Chief Medical Officer | 13 Nov 2019 | 12,760 | 78,887 (0%) | 0% | 0 | Common Stock | ||
| Nora E. Brennan | Chief Financial Officer | 13 Nov 2019 | 3,491 | 3,668 (0%) | 0% | 0 | Common Stock | ||
| Nora E. Brennan | Chief Financial Officer | 13 Nov 2019 | 86,200 | 0 | - | - | Series B Preferred Stock | ||
| Ellis Skott Greenhalgh | Chief Science Officer | 13 Nov 2019 | 50,000 | 0 | - | - | Series A Preferred Stock | ||
| Ellis Skott Greenhalgh | Chief Science Officer | 13 Nov 2019 | 4,887 | 10,510 (0%) | 0% | 0 | Common Stock | ||
| Ellis Skott Greenhalgh | Chief Science Officer | 13 Nov 2019 | 2,025 | 5,623 (0%) | 0% | 0 | Common Stock | ||
| Ellis Skott Greenhalgh | Chief Science Officer | 13 Nov 2019 | 1,976 | 0 | - | - | Warrant (right to buy) | ||
| Ellis Skott Greenhalgh | Chief Science Officer | 13 Nov 2019 | 120,699 | 0 | - | - | Series B Preferred Stock | ||
| Ellis Skott Greenhalgh | Chief Science Officer | 13 Nov 2019 | 1,976 | 1,976 | - | - | Warrant (right to buy) | ||
| Ronald Ellis | Director, Ten Percent Owner | 13 Nov 2019 | 14,329,052 | 0 | - | - | Series B Preferred Stock | ||
| Ronald Ellis | Director, Ten Percent Owner | 13 Nov 2019 | 580,357 | 774,056 (7%) | 5% | 0 | Common Stock | ||
| Ashley Friedman | None | 13 Nov 2019 | 285,580 | 505,281 (4%) | 2% | 0 | Common Stock | ||
| Ashley Friedman | None | 13 Nov 2019 | 148,499 | 148,499 | - | - | Warrant (right to buy) | ||
| Ashley Friedman | None | 13 Nov 2019 | 148,499 | 0 | - | - | Warrant (right to buy) | ||
| Ashley Friedman | None | 13 Nov 2019 | 31,168 | 31,168 | - | - | Warrant (right to buy) | ||
| Ashley Friedman | None | 13 Nov 2019 | 31,168 | 0 | - | - | Warrant (right to buy) | ||
| Ashley Friedman | None | 13 Nov 2019 | 7,051,009 | 0 | - | - | Series B Preferred Stock | ||
| Ashley Friedman | None | 13 Nov 2019 | 1,479,951 | 0 | - | - | Series B Preferred Stock | ||
| Ashley Friedman | None | 13 Nov 2019 | 59,940 | 106,052 (0%) | 0% | 0 | Common Stock | ||
| Adele C. Oliva | Director, Ten Percent Owner | 08 Nov 2019 | 446,813 | 446,813 | - | - | Warrant (right to buy) | ||
| Adele C. Oliva | Director, Ten Percent Owner | 08 Nov 2019 | 446,813 | 0 | - | - | Warrant (right to buy) | ||
| Adele C. Oliva | Director, Ten Percent Owner | 08 Nov 2019 | 12,763,434 | 0 | - | - | Series B Preferred Stock | ||
| Adele C. Oliva | Director, Ten Percent Owner | 08 Nov 2019 | 8,530,145 | 0 | - | - | Series A Preferred Stock | ||
| Adele C. Oliva | Director, Ten Percent Owner | 08 Nov 2019 | 516,947 | 1,751,100 (15%) | 4% | 0 | Common Stock | ||
| Adele C. Oliva | Director, Ten Percent Owner | 08 Nov 2019 | 345,489 | 1,234,153 (11%) | 3% | 0 | Common Stock | ||
| Adele C. Oliva | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 08 Nov 2019 | 153,846 | 888,664 (8%) | 1% | 13 | 1,999,998 | Common Stock |
| Kurt Azarbarzin | None | 08 Nov 2019 | 72,417 | 0 | - | - | Series B Preferred Stock | ||
| Kurt Azarbarzin | None | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 08 Nov 2019 | 10,220 | 12,675 (0%) | 0% | 13 | 132,860 | Common Stock |
| Kurt Azarbarzin | None | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 08 Nov 2019 | 75,901 | 260,808 (2%) | 0% | 13 | 986,713 | Common Stock |
| Kurt Azarbarzin | None | 08 Nov 2019 | 269 | 12,944 (0%) | 0% | 0 | Common Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 2,931 | 15,875 (0%) | 0% | 0 | Common Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 19,982 | 280,790 (2%) | 0% | 0 | Common Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 217,816 | 498,606 (4%) | 1% | 0 | Common Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 493,357 | 0 | - | - | Series A Preferred Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 6,643 | 0 | - | - | Series A Preferred Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 5,377,928 | 0 | - | - | Series B Preferred Stock | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 123,653 | 0 | - | - | Warrant (right to buy) | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 123,653 | 123,653 | - | - | Warrant (right to buy) | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 1,665 | 0 | - | - | Warrant (right to buy) | ||
| Kurt Azarbarzin | None | 08 Nov 2019 | 1,665 | 1,665 | - | - | Warrant (right to buy) | ||
| Matt Zuga | None | 08 Nov 2019 | 217,816 | 498,606 (4%) | 1% | 0 | Common Stock | ||
| Matt Zuga | None | 08 Nov 2019 | 493,357 | 0 | - | - | Series A Preferred Stock | ||
| Matt Zuga | None | 08 Nov 2019 | 5,377,928 | 0 | - | - | Series B Preferred Stock | ||
| Matt Zuga | None | 08 Nov 2019 | 6,643 | 0 | - | - | Series A Preferred Stock | ||
| Matt Zuga | None | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 08 Nov 2019 | 10,220 | 12,675 (0%) | 0% | 13 | 132,860 | Common Stock |
| Matt Zuga | None | 08 Nov 2019 | 123,653 | 0 | - | - | Warrant (right to buy) | ||
| Matt Zuga | None | 08 Nov 2019 | 72,417 | 0 | - | - | Series B Preferred Stock | ||
| Matt Zuga | None | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 08 Nov 2019 | 75,901 | 260,808 (2%) | 0% | 13 | 986,713 | Common Stock |
| Matt Zuga | None | 08 Nov 2019 | 269 | 12,944 (0%) | 0% | 0 | Common Stock | ||
| Matt Zuga | None | 08 Nov 2019 | 2,931 | 15,875 (0%) | 0% | 0 | Common Stock | ||
| Matt Zuga | None | 08 Nov 2019 | 19,982 | 280,790 (2%) | 0% | 0 | Common Stock | ||
| Matt Zuga | None | 08 Nov 2019 | 1,665 | 1,665 | - | - | Warrant (right to buy) | ||
| Matt Zuga | None | 08 Nov 2019 | 1,665 | 0 | - | - | Warrant (right to buy) | ||
| Matt Zuga | None | 08 Nov 2019 | 123,653 | 123,653 | - | - | Warrant (right to buy) |